| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/27/2006 | US7067712 Transgenic animal; animal models; gene expression; skin disorders |
| 06/27/2006 | US7067667 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 06/27/2006 | US7067649 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis. |
| 06/27/2006 | US7067619 Integrin-binding peptides |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067543 Anthranilic acid amides and pharmaceutical use thereof |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067537 Anticancer, antitumor agents |
| 06/27/2006 | US7067535 5-Phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol |
| 06/27/2006 | US7067521 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7pyridinyl-imidazo[1,2-alpha]pyrimidin-5(1H)-one derivatives |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067514 Pyrimidine compounds |
| 06/27/2006 | US7067512 Substituted 1,4-benzodiazepines and uses thereof |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067496 Transplanting into dermis, least one hair follicle that has been modified ex vivo to contain nucleic acid molecule to introduce nucleic acid molecule into mammal |
| 06/27/2006 | US7067492 Method of promoting healing of a tympanic membrane perforation |
| 06/27/2006 | US7067480 Compositions and methods of use for anti-inflammatory agents |
| 06/27/2006 | US7067474 A peptide or polypeptide obtained from the armadillo domain of human beta -catenin polypeptide which inhibits the interaction of human beta -catenin polypeptide and a transcription factor or tumor suppressor protein |
| 06/27/2006 | US7067285 Desaturase genes and uses thereof |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/22/2006 | WO2006065852A1 Methods of using grape seed extract to stimulate tyrosinase expression or melanin synthesis |
| 06/22/2006 | WO2006064975A1 Composition and method for accelerating fibulin-5 production and/or enhancing fibulin-5 activity |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006063865A2 Compositions for enhancing keratinocyte migration and epidermal repair via a receptor containing osmrbeta as a subunit, and applications thereof |
| 06/22/2006 | WO2006063864A2 Compositions for preventing, reducing or treating keratinocyte-mediated inflammation |
| 06/22/2006 | WO2006063811A2 Substituted 1,2,4-triazin-5(2h)-ones |
| 06/22/2006 | WO2006063714A1 Pharmaceutical compositions for the treatment of cellulite |
| 06/22/2006 | WO2006063518A1 Multifunctional polypeptides |
| 06/22/2006 | WO2006063402A1 Therapeutic compositions based on extracts of plants from the genus plumeria (frangipani) |
| 06/22/2006 | US20060136136 Crystal structure of baff, and use thereof in drug design |
| 06/22/2006 | US20060135622 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 06/22/2006 | US20060135618 Medicine comprising a thiourea for use as depigmenting agent or anti-mutagenic and anti-carcinogenic agent |
| 06/22/2006 | US20060135614 Novel compounds |
| 06/22/2006 | US20060135590 Selected fused pyrrolocarbazoles |
| 06/22/2006 | US20060135587 Method and compounds for promoting healing and reducing inflammation |
| 06/22/2006 | US20060135583 e.g. 4-[3'-(3''-aminosulfonylpropyl)-4',4'-dimethyl-5'-oxo-2'-thioxo-1'-imidazolidinyl]-2-trifluoromethylbenzonitrile; anti-androgen agent which has a sufficient antagonistic effect and reduced side effect profile |
| 06/22/2006 | US20060135580 One step reaction of compound such as 3,5-dimethyl-isoxazole with butlyllithium and (3,5-di-tert-butyl)-4-hydroxybenzaldehyde, recrystallization/dehydration alcohol in the presence of a base to give (E)-5-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)vinyl]-3-methylisoxazole |
| 06/22/2006 | US20060135577 EDG (Endothelial differentiation gene)-2 antagonist; chronic asthma, glomerular nephritis, obesity, prostate hyperplasia, arteriosclerosis, atopic dermatitis; (1) 3-(N-((2-(2-((4-chlorobenzylamino)carbonyl)phenyl)phenyl)carbonyl)-N-(2-(2-methoxyphenyl)ethyl)amino)propanoic acid |
| 06/22/2006 | US20060135573 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/22/2006 | US20060135543 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 06/22/2006 | US20060135534 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/22/2006 | US20060135508 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | US20060135493 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 06/22/2006 | US20060135492 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 06/22/2006 | US20060135448 Hydroxypyridinones for the local treatment of skin microcirculatroy disorders |
| 06/22/2006 | US20060135431 Peptides and related molecules that bind to TALL-1 |
| 06/22/2006 | US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/22/2006 | US20060134128 Screening for an inhibitor of binding between human Toll-like receptor 3 and a protein of specific amino acid sequence by contacting a candidate with a transfected cell encoding the protein which expresses the receptor; increased interferon in vivo; antitumor, autoimmune agents; side effect reduction |
| 06/22/2006 | US20060134095 Antioxidative composition and composition for external use |
| 06/22/2006 | US20060134039 Nail restructuring compositions for topical application |
| 06/22/2006 | CA2767026A1 Protein formulation for administering an active enamel substance |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2590288A1 Pharmaceutical compositions for the treatment of cellulite |
| 06/22/2006 | CA2590095A1 Compositions comprising oncostatin m for enhancing keratinocyte migration and epidermal repair |
| 06/22/2006 | CA2589670A1 Compositions for preventing, reducing or treating keratinocyte-mediated inflammation |
| 06/22/2006 | CA2530963A1 Phototherapy compositions and methods |
| 06/21/2006 | EP1671965A2 Oxacarbocyclic oligomers of fumaric acid |
| 06/21/2006 | EP1671961A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1671950A1 Cinnamoyl derivatives and use thereof |
| 06/21/2006 | EP1671948A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1671655A1 Gene therapy for skin diseases using needle free syringe |
| 06/21/2006 | EP1671652A1 Use of chitosan for the treatment of pruritus |
| 06/21/2006 | EP1671642A1 Compositions comprising (ant)agonists of oncostatin M (OSM), IL-31 and IFN-gamma for modulating keratinocyte migration and functions via a receptor containing OSMRbeta as a subunit, and applications thereof. |
| 06/21/2006 | EP1671632A1 Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors |
| 06/21/2006 | EP1671629A1 Human beta-defensin secretion promoter |
| 06/21/2006 | EP1671616A1 Hair tonic composition |
| 06/21/2006 | EP1670488A1 Use of oxygen in cosmetic or dermatological preparations |
| 06/21/2006 | EP1670418A2 Chitosan spinning method, device therefor, and resulting chitosan yarn, and uses thereof |
| 06/21/2006 | EP1443915B1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 06/21/2006 | EP1438316B1 Phosphonic acid compounds as inhibitors of serine proteases |
| 06/21/2006 | EP1383508B1 Doxycycline for the treatment of acne |
| 06/21/2006 | EP1284952B1 Substituted chalcones as therapeutic compounds |
| 06/21/2006 | EP1282599B1 Disulfide derivatives useful for treating allergic diseases |
| 06/21/2006 | EP1244647B1 Quinazoline derivatives as vegf inhibitors |
| 06/21/2006 | EP1189931B1 Peptide compounds that bind her2 |
| 06/21/2006 | EP1178816B1 Materials for soft tissue augmentation and methods of making and using same |
| 06/21/2006 | CN1791594A 2-aminoquinoline derivative |
| 06/21/2006 | CN1791575A Cyanofluoropyrrolidine derivative. |
| 06/21/2006 | CN1791425A C1 inhibitor with short half-life for transient treatment |
| 06/21/2006 | CN1791412A Novel compounds and their use in therapy |
| 06/21/2006 | CN1789264A Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof |
| 06/21/2006 | CN1788790A Extrasin beta-16 for promoting vascularization, tissue regeneration and wound healing |
| 06/21/2006 | CN1788789A Anti-inflammatory action of oxidation type extrasin beta-10 |
| 06/21/2006 | CN1788774A Medicament for treating psoriasis |
| 06/21/2006 | CN1788769A Sumatra dragonsblood soft capsule and its preparation method |
| 06/21/2006 | CN1788768A Traditional Chinese medicine composition for removing facial erythema and its uses |
| 06/21/2006 | CN1788766A Oral Chinese traditional medicine for treating diabetes foot |
| 06/21/2006 | CN1788759A Externally-used embrocation for scald |
| 06/21/2006 | CN1788744A Ciliate desert-grass effective parts formulation resin processing method |
| 06/21/2006 | CN1788734A Selenium sulfide nano particle additive preparing method and use |
| 06/21/2006 | CN1788733A Gel agent containing centella general glycoside and sodium hyaluronate, its preparation method and uses |
| 06/21/2006 | CN1788730A Gel drop and spray agent containing centella general glycoside and sodium hyaluronate |
| 06/21/2006 | CN1788590A Dairy product or drink for resisting oxidation, regulating blood , nursing heart and delaying aging |